An Extension Study of Telbivudine, Lamivudine or Telbivudine Plus Lamivudine in Patients With Chronic Hepatitis B
Status:
Completed
Trial end date:
2005-11-01
Target enrollment:
Participant gender:
Summary
This is an extension study for patients who have previously completed Idenix Study
NV-02B-003. This study is being conducted to compare the safety and effectiveness of
treatment beyond 1 year of telbivudine and telbivudine combined with lamivudine, a drug
currently approved for the treatment of hepatitis B.